The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

HealthSouth Corp

NYSE: HLS
Last

(U.S.) $40.26

Today's change-0.19 -0.47%
Updated December 26 11:18 AM EST. Delayed by at least 15 minutes.
 

HealthSouth Corp

NYSE: HLS
Last

(U.S.) $40.26

Today's change-0.19 -0.47%
Updated December 26 11:18 AM EST. Delayed by at least 15 minutes.

HealthSouth Corp down (U.S.)$0.19

HealthSouth Corp is lower today, dropping (U.S.)$0.19 or 0.47% to (U.S.)$40.26. Over the last five days, shares have gained 0.32% and 20.83% year to date. Shares have outperformed the S&P 500 by 5.80% during the last year.

Key company metrics

  • Open(U.S.) $40.68
  • Previous close(U.S.) $40.45
  • High(U.S.) $40.68
  • Low(U.S.) $40.25
  • Bid / Ask(U.S.) $40.26 / (U.S.) $40.29
  • YTD % change+20.83%
  • Volume61,152
  • Average volume (10-day)737,429
  • Average volume (1-month)556,376
  • Average volume (3-month)499,117
  • 52-week range(U.S.) $29.82 to (U.S.) $42.41
  • Beta1.71
  • Trailing P/E26.49×
  • P/E 1 year forward19.78×
  • Forward PEG4.71×
  • Indicated annual dividend(U.S.) $0.84
  • Dividend yield2.09%
  • Trailing EPS(U.S.) $1.52
Updated December 26 11:18 AM EST. Delayed by at least 15 minutes.
S&P TSX0.10%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue589595584569
Total other revenue--------
Total revenue589595584569
Gross profit562567556541
Total cost of revenue27282827
Total operating expense475468467452
Selling / general / administrative332328329316
Research & development--------
Depreciation / amortization27262625
Interest expense (income), net operating--------
Unusual expense (income)0-1--2
Other operating expenses, total89868582
Operating income114128116117
Interest income (expense), net non-operating-28-28-28-27
Gain (loss) on sale of assets--------
Other--------
Income before tax881319495
Income after tax66946264
Income tax, total22373331
Net income50834749
Total adjustments to net income-2-3-2-75
Net income before extra. items51794749
Minority interest-15-15-15-15
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items497745-27
Inc. avail. to common incl. extra. items488045-27
Diluted net income528549-27
Dilution adjustment4540
Diluted weighted average shares10110110186
Diluted EPS excluding extraordinary itemsvalue per share0.530.810.49-0.31
Dividends per sharevalue per share0.210.180.180.18
Diluted normalized EPSvalue per share0.550.820.49-0.28